logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Bumelyte, Diana
    Born in August 1974
    Individual (2 offsprings)
    Officer
    2016-04-19 ~ 2020-09-01
    OF - Director → CIF 0
    Miss Diana Bumelyte
    Born in August 1974
    Individual (2 offsprings)
    Person with significant control
    2017-04-06 ~ 2017-04-06
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Bumelis, Vladas Algirdas
    Born in July 1949
    Individual (2 offsprings)
    Officer
    2020-09-01 ~ now
    OF - Director → CIF 0
  • 3
    Jakelyte, Vaiva
    Individual (1 offspring)
    Officer
    2016-10-10 ~ 2020-09-01
    OF - Secretary → CIF 0
  • 4
    NORTHWAY HOLDINGS LIMITED
    04691066
    Suite 1, 3rd Floor, 11-12 St. James's Square, London, England
    Active Corporate (14 parents, 3 offsprings)
    Person with significant control
    2016-06-27 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

NORTHWAY BIOTECH (UK) LTD.

Period: 2020-09-02 ~ now
Company number: 10133949
Registered names
NORTHWAY BIOTECH (UK) LTD. - now
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Debtors
1,894 GBP2024-12-31
14,224 GBP2023-12-31
Cash at bank and in hand
31,828 GBP2024-12-31
19,308 GBP2023-12-31
Current Assets
33,722 GBP2024-12-31
33,532 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-21,809 GBP2024-12-31
-23,175 GBP2023-12-31
Net Current Assets/Liabilities
11,913 GBP2024-12-31
10,357 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
Retained earnings (accumulated losses)
11,813 GBP2024-12-31
10,257 GBP2023-12-31
Equity
11,913 GBP2024-12-31
10,357 GBP2023-12-31
Other Debtors
Current, Amounts falling due within one year
1,894 GBP2024-12-31
14,224 GBP2023-12-31
Trade Creditors/Trade Payables
Current
0 GBP2024-12-31
1,646 GBP2023-12-31
Amounts owed to group undertakings
Current
13,000 GBP2024-12-31
13,000 GBP2023-12-31
Other Taxation & Social Security Payable
Current
0 GBP2024-12-31
72 GBP2023-12-31
Other Creditors
Current
8,809 GBP2024-12-31
8,457 GBP2023-12-31
Creditors
Current
21,809 GBP2024-12-31
23,175 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Average Number of Employees
32024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31

  • NORTHWAY BIOTECH (UK) LTD.
    Info
    TREATMENT OVERSEAS LTD - 2020-09-02
    Registered number 10133949
    Unit 121 Meridian Place, London E14 9FE
    PRIVATE LIMITED COMPANY incorporated on 2016-04-19 (10 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-08
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.